NZ600156A - Degradable removable implant for the sustained release of an active compound - Google Patents
Degradable removable implant for the sustained release of an active compoundInfo
- Publication number
- NZ600156A NZ600156A NZ600156A NZ60015610A NZ600156A NZ 600156 A NZ600156 A NZ 600156A NZ 600156 A NZ600156 A NZ 600156A NZ 60015610 A NZ60015610 A NZ 60015610A NZ 600156 A NZ600156 A NZ 600156A
- Authority
- NZ
- New Zealand
- Prior art keywords
- microparticles
- sustained release
- degradable
- active compound
- implant
- Prior art date
Links
- 239000007943 implant Substances 0.000 title abstract 3
- 238000013268 sustained release Methods 0.000 title abstract 2
- 239000012730 sustained-release form Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 239000011859 microparticle Substances 0.000 abstract 6
- 239000013543 active substance Substances 0.000 abstract 2
- 230000015556 catabolic process Effects 0.000 abstract 2
- 238000006731 degradation reaction Methods 0.000 abstract 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 abstract 1
- 229920002988 biodegradable polymer Polymers 0.000 abstract 1
- 239000004621 biodegradable polymer Substances 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 229920006237 degradable polymer Polymers 0.000 abstract 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- YIBOMRUWOWDFLG-ONEGZZNKSA-N rilpivirine Chemical compound CC1=CC(\C=C\C#N)=CC(C)=C1NC1=CC=NC(NC=2C=CC(=CC=2)C#N)=N1 YIBOMRUWOWDFLG-ONEGZZNKSA-N 0.000 abstract 1
- 229960002814 rilpivirine Drugs 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28837309P | 2009-12-21 | 2009-12-21 | |
| PCT/EP2010/070246 WO2011080141A2 (en) | 2009-12-21 | 2010-12-20 | Degradable removable implant for the sustained release of an active compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ600156A true NZ600156A (en) | 2015-01-30 |
Family
ID=43743502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ600156A NZ600156A (en) | 2009-12-21 | 2010-12-20 | Degradable removable implant for the sustained release of an active compound |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US8784858B2 (https=) |
| EP (1) | EP2515877B1 (https=) |
| JP (1) | JP5950825B2 (https=) |
| KR (1) | KR101798430B1 (https=) |
| CN (1) | CN102740837B (https=) |
| AU (1) | AU2010338425B2 (https=) |
| BR (1) | BR112012015114B1 (https=) |
| CA (1) | CA2784530C (https=) |
| ES (1) | ES2600878T3 (https=) |
| IL (1) | IL219685B (https=) |
| MX (1) | MX2012007210A (https=) |
| MY (1) | MY163383A (https=) |
| NZ (1) | NZ600156A (https=) |
| RU (1) | RU2593790C2 (https=) |
| SG (1) | SG181759A1 (https=) |
| UA (1) | UA112155C2 (https=) |
| WO (1) | WO2011080141A2 (https=) |
| ZA (1) | ZA201204583B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1224020A1 (zh) * | 2013-06-20 | 2017-08-11 | Mercy Medical Research Institute | 延长释放药物传递的隐形眼镜及其制造方法 |
| EP4574179A3 (en) | 2014-08-15 | 2025-10-01 | The Johns Hopkins University | Composite material for tissue restoration |
| WO2016149561A1 (en) * | 2015-03-17 | 2016-09-22 | Oak Crest Institute Of Science | Subdermal implants for the sustained delivery of water-soluble drugs |
| US11779435B2 (en) | 2015-08-26 | 2023-10-10 | Flexscrewdriver I.K.E. | Dental screwdriver |
| CN106702597B (zh) * | 2016-12-20 | 2019-06-18 | 华南理工大学 | 一种核-壳结构纳米纤维膜及其制备方法和应用 |
| AU2018300080B2 (en) | 2017-07-11 | 2024-09-19 | Sustained Nano Systems Llc | Hypercompressed pharmaceutical formulations |
| CA3099732A1 (en) | 2018-05-09 | 2019-11-14 | The Johns Hopkins University | Nanofiber-hydrogel composites for cell and tissue delivery |
| ES3060255T3 (en) | 2018-05-09 | 2026-03-25 | Univ Johns Hopkins | Nanofiber-hydrogel composites for enhanced soft tissue replacement and regeneration |
| WO2019222482A1 (en) * | 2018-05-16 | 2019-11-21 | Spirox, Inc. | Allergic rhinitis drug delivery implant |
| KR20210060631A (ko) | 2018-10-16 | 2021-05-26 | 리써치 트라이앵글 인스티튜트 | 피하 생분해성 저장소 디바이스 |
| JP2023521653A (ja) * | 2020-04-07 | 2023-05-25 | リサーチ トライアングル インスティテュート | 皮下用生分解性リザーバ装置のための多剤製剤 |
| EP4151673A4 (en) * | 2020-05-12 | 2024-03-20 | Laboratorios Farmacéuticos Rovi, S.A. | METHOD FOR THE PURIFICATION OF BIODEGRADABLE THERMOPLASTIC POLYMER PARTICLES FOR MEDICAL AND/OR PHARMACEUTICAL USE |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5182111A (en) | 1987-11-17 | 1993-01-26 | Boston University Research Foundation | In vivo delivery of active factors by co-cultured cell implants |
| EP0610441A4 (en) * | 1991-10-29 | 1996-01-10 | Clover Cons Ltd | CROSSLINKABLE POLYSACCHARIDES, POLYCATIONS AND LIPIDS CAN BE USED TO ENCODE AND DISPENSE MEDICINAL PRODUCTS. |
| US5645684A (en) | 1994-03-07 | 1997-07-08 | The Regents Of The University Of California | Multilayer high vertical aspect ratio thin film structures |
| US5660680A (en) | 1994-03-07 | 1997-08-26 | The Regents Of The University Of California | Method for fabrication of high vertical aspect ratio thin film structures |
| US5651900A (en) | 1994-03-07 | 1997-07-29 | The Regents Of The University Of California | Microfabricated particle filter |
| EP0749474A4 (en) | 1994-03-07 | 1997-09-17 | Univ California | MICRO-MADE CAPSULES FOR INSULATING CELL TRANSPLANTS |
| US5798042A (en) | 1994-03-07 | 1998-08-25 | Regents Of The University Of California | Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters |
| CN1378445B (zh) | 1999-08-06 | 2013-02-06 | 得克萨斯系统大学评议会 | 药物释放生物可降解纤维植入物 |
| US7033603B2 (en) * | 1999-08-06 | 2006-04-25 | Board Of Regents The University Of Texas | Drug releasing biodegradable fiber for delivery of therapeutics |
| EP1222192B8 (en) | 1999-10-06 | 2008-10-01 | Tibotec Pharmaceuticals Ltd. | Hexahydrofuro¬2,3-b furan-3-yl-n- 3-¬(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino -1-benzyl-2-hydroxypropyl carbamate as retroviral protease inhibitor |
| TWI284048B (en) | 2000-01-27 | 2007-07-21 | Zentaris Ag | Compressed microparticles for dry injection |
| US20040115268A1 (en) * | 2000-04-26 | 2004-06-17 | Control Delivery Systems, Inc. | Systemic delivery of antiviral agents |
| DE10050199A1 (de) * | 2000-10-11 | 2002-04-25 | Ethicon Gmbh | Flächiges Implantat mit im Ultraschall detektierbaren Elementen |
| KR20030096381A (ko) * | 2001-05-11 | 2003-12-24 | 오쏘-맥네일 파머슈티칼 인코퍼레이티드 | 동물에 사용하기 위한 면역 조절장치 |
| MY169670A (en) | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
| WO2004022033A1 (en) | 2002-09-04 | 2004-03-18 | Microchips, Inc. | Method and device for the controlled delivery of parathyroid hormone |
| US20040156878A1 (en) | 2003-02-11 | 2004-08-12 | Alireza Rezania | Implantable medical device seeded with mammalian cells and methods of treatment |
| TW201414495A (zh) * | 2005-04-04 | 2014-04-16 | Tibotec Pharm Ltd | Ｈｉｖ-感染之預防 |
| EP1872390A2 (en) | 2005-04-11 | 2008-01-02 | The Board of Trustees of the Leland Stanford Junior University | Multi-layer structure having a predetermined layer pattern including an agent |
| US20060252049A1 (en) | 2005-05-04 | 2006-11-09 | Shuler Richard O | Growth-promoting and immunizing subcutaneous implant |
| US7261529B2 (en) | 2005-09-07 | 2007-08-28 | Southwest Research Institute | Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agents |
| BRPI0707179A2 (pt) * | 2006-01-20 | 2011-04-26 | Tibotec Pharm Ltd | tratamento de longo termo de infecção por hiv |
| WO2008060360A2 (en) * | 2006-09-28 | 2008-05-22 | Surmodics, Inc. | Implantable medical device with apertures for delivery of bioactive agents |
| AR066972A1 (es) * | 2007-06-12 | 2009-09-23 | Concert Pharmaceuticals Inc | Derivados azapeptidicos |
| WO2009046299A2 (en) * | 2007-10-04 | 2009-04-09 | Boston Scientific Scimed, Inc | Implantable drug depot for intrathecal drug delivery system for pain management |
| US20110257111A1 (en) * | 2008-10-24 | 2011-10-20 | Harbeson Scott L | Hydroxyethlamino Sulfonamide Derivatives |
| WO2010072844A1 (en) | 2008-12-24 | 2010-07-01 | Tibotec Pharmaceuticals | Implantable devices for treating hiv |
-
2010
- 2010-12-20 UA UAA201206035A patent/UA112155C2/uk unknown
- 2010-12-20 SG SG2012044541A patent/SG181759A1/en unknown
- 2010-12-20 EP EP10803585.8A patent/EP2515877B1/en active Active
- 2010-12-20 CA CA2784530A patent/CA2784530C/en active Active
- 2010-12-20 WO PCT/EP2010/070246 patent/WO2011080141A2/en not_active Ceased
- 2010-12-20 BR BR112012015114-2A patent/BR112012015114B1/pt not_active IP Right Cessation
- 2010-12-20 NZ NZ600156A patent/NZ600156A/en not_active IP Right Cessation
- 2010-12-20 KR KR1020127016179A patent/KR101798430B1/ko active Active
- 2010-12-20 ES ES10803585.8T patent/ES2600878T3/es active Active
- 2010-12-20 MX MX2012007210A patent/MX2012007210A/es active IP Right Grant
- 2010-12-20 US US13/515,380 patent/US8784858B2/en active Active
- 2010-12-20 RU RU2012131282/15A patent/RU2593790C2/ru active
- 2010-12-20 CN CN201080058303.9A patent/CN102740837B/zh not_active Expired - Fee Related
- 2010-12-20 AU AU2010338425A patent/AU2010338425B2/en active Active
- 2010-12-20 MY MYPI2012002730A patent/MY163383A/en unknown
- 2010-12-20 JP JP2012543843A patent/JP5950825B2/ja not_active Expired - Fee Related
-
2012
- 2012-05-09 IL IL219685A patent/IL219685B/en active IP Right Grant
- 2012-06-20 ZA ZA2012/04583A patent/ZA201204583B/en unknown
-
2014
- 2014-06-10 US US14/300,607 patent/US10744235B2/en active Active
-
2020
- 2020-06-30 US US16/917,269 patent/US11395867B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102740837B (zh) | 2017-06-06 |
| EP2515877B1 (en) | 2016-08-10 |
| AU2010338425B2 (en) | 2015-07-23 |
| RU2012131282A (ru) | 2014-01-27 |
| MX2012007210A (es) | 2012-07-23 |
| AU2010338425A1 (en) | 2012-06-07 |
| JP2013514971A (ja) | 2013-05-02 |
| US20120277690A1 (en) | 2012-11-01 |
| MY163383A (en) | 2017-09-15 |
| US8784858B2 (en) | 2014-07-22 |
| US20200330654A1 (en) | 2020-10-22 |
| ES2600878T3 (es) | 2017-02-13 |
| US20140296799A1 (en) | 2014-10-02 |
| SG181759A1 (en) | 2012-07-30 |
| US11395867B2 (en) | 2022-07-26 |
| CN102740837A (zh) | 2012-10-17 |
| BR112012015114A2 (pt) | 2020-09-01 |
| US10744235B2 (en) | 2020-08-18 |
| WO2011080141A2 (en) | 2011-07-07 |
| WO2011080141A3 (en) | 2012-03-08 |
| BR112012015114B1 (pt) | 2023-01-10 |
| IL219685B (en) | 2019-03-31 |
| CA2784530A1 (en) | 2011-07-07 |
| EP2515877A2 (en) | 2012-10-31 |
| JP5950825B2 (ja) | 2016-07-13 |
| RU2593790C2 (ru) | 2016-08-10 |
| CA2784530C (en) | 2018-05-22 |
| ZA201204583B (en) | 2022-03-30 |
| KR101798430B1 (ko) | 2017-11-16 |
| UA112155C2 (uk) | 2016-08-10 |
| IL219685A0 (en) | 2012-07-31 |
| KR20120101084A (ko) | 2012-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ600156A (en) | Degradable removable implant for the sustained release of an active compound | |
| MX2010003813A (es) | Implante medico biodegradable in vivo. | |
| WO2009005909A3 (en) | Biodegradable triblock copolymers for implantable devices | |
| EP2404626A3 (en) | Surgical implants | |
| HK1208829A1 (en) | Shape memory bioresorbable polymer peripheral scaffolds | |
| WO2012034049A3 (en) | Implantable medical devices having double walled microspheres | |
| IL219395A0 (en) | Biodegradable implantable medical devices formed from super-pure magnesium-based material | |
| CA2873879A1 (en) | Vascular occlusion and drug delivery devices, systems, and methods | |
| EP2380599A3 (en) | Biactive substance in a barbed suture | |
| NZ610341A (en) | Drug-eluting self-retaining sutures and methods relating thereto | |
| JP2013514971A5 (https=) | ||
| WO2010068381A3 (en) | Implantable medical devices having multiblock copolymers | |
| WO2008127889A3 (en) | Degradable polymers incorporating gamma- butyrolactone | |
| WO2007038625A3 (en) | Biodegradable nanocomposites with enhanced mechanical properties for soft tissue engineering. | |
| WO2010062523A3 (en) | Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof | |
| EP4406535A3 (en) | Prostamide-containing intraocular implants and methods of use thereof | |
| WO2010005723A3 (en) | Drug loaded polymeric nanoparticles and methods of making and using same | |
| WO2012166923A3 (en) | Drug loaded polymeric nanoparticles and methods of making and using same | |
| NZ607797A (en) | Corticosteroids for the treatment of joint pain | |
| MY165655A (en) | Biodegradable drug delivery compositions | |
| MX2009001230A (es) | Implantes subcutaneos que liberan un principio activo durante un periodo de tiempo extendido. | |
| WO2010061288A3 (en) | Polymeric pharmaceutical dosage form in sustained release | |
| JP2011508791A5 (https=) | ||
| NZ628913A (en) | Segmented, semicrystalline poly(lactide-co-epsilon-caprolactone) absorbable copolymers | |
| WO2010099292A3 (en) | Biodegradable drug or other active delivery system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 20 DEC 2017 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20150612 |
|
| ASS | Change of ownership |
Owner name: JANSSEN SCIENCES IRELAND UC, IE Effective date: 20150723 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 DEC 2018 BY CPA GLOBAL Effective date: 20171102 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 DEC 2019 BY CPA GLOBAL Effective date: 20181108 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 DEC 2020 BY CPA GLOBAL Effective date: 20191107 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 DEC 2021 BY CPA GLOBAL Effective date: 20201105 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 DEC 2022 BY CPA GLOBAL Effective date: 20211104 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 DEC 2023 BY CPA GLOBAL Effective date: 20221108 |
|
| LAPS | Patent lapsed |